104 related articles for article (PubMed ID: 25434383)
1. Wilms tumor 1 gene, CD97, and the emerging biogenetic profile of glioblastoma.
Somasundaram A; Ardanowski N; Opalak CF; Fillmore HL; Chidambaram A; Broaddus WC
Neurosurg Focus; 2014 Dec; 37(6):E14. PubMed ID: 25434383
[TBL] [Abstract][Full Text] [Related]
2. Novel report of expression and function of CD97 in malignant gliomas: correlation with Wilms tumor 1 expression and glioma cell invasiveness.
Chidambaram A; Fillmore HL; Van Meter TE; Dumur CI; Broaddus WC
J Neurosurg; 2012 Apr; 116(4):843-53. PubMed ID: 22313360
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients.
Safaee M; Clark AJ; Oh MC; Ivan ME; Bloch O; Kaur G; Sun MZ; Kim JM; Oh T; Berger MS; Parsa AT
PLoS One; 2013; 8(4):e62765. PubMed ID: 23658650
[TBL] [Abstract][Full Text] [Related]
4. Proportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cells.
Safaee M; Fakurnejad S; Bloch O; Clark AJ; Ivan ME; Sun MZ; Oh T; Phillips JJ; Parsa AT
PLoS One; 2015; 10(2):e0111532. PubMed ID: 25714433
[TBL] [Abstract][Full Text] [Related]
5. CD97 is associated with mitogenic pathway activation, metabolic reprogramming, and immune microenvironment changes in glioblastoma.
Safaee MM; Wang EJ; Jain S; Chen JS; Gill S; Zheng AC; Garcia JH; Beniwal AS; Tran Y; Nguyen AT; Trieu M; Leung K; Wells J; Maclean JM; Wycoff K; Aghi MK
Sci Rep; 2022 Jan; 12(1):1464. PubMed ID: 35087132
[TBL] [Abstract][Full Text] [Related]
6. WT1/EGR1-mediated control of STIM1 expression and function in cancer cells.
Ritchie MF; Zhou Y; Soboloff J
Front Biosci (Landmark Ed); 2011 Jun; 16(7):2402-15. PubMed ID: 21622185
[TBL] [Abstract][Full Text] [Related]
7. Identification of WTAP, a novel Wilms' tumour 1-associating protein.
Little NA; Hastie ND; Davies RC
Hum Mol Genet; 2000 Sep; 9(15):2231-9. PubMed ID: 11001926
[TBL] [Abstract][Full Text] [Related]
8. Wilms tumor 1 expression in malignant gliomas and correlation of +KTS isoforms with p53 status.
Clark AJ; Dos Santos WG; McCready J; Chen MY; Van Meter TE; Ware JL; Wolber SB; Fillmore H; Broaddus WC
J Neurosurg; 2007 Sep; 107(3):586-92. PubMed ID: 17886559
[TBL] [Abstract][Full Text] [Related]
9. Effect of WT1 gene silencing on the tumorigenicity of human glioblastoma multiforme cells.
Clark AJ; Ware JL; Chen MY; Graf MR; Van Meter TE; Dos Santos WG; Fillmore HL; Broaddus WC
J Neurosurg; 2010 Jan; 112(1):18-25. PubMed ID: 19392599
[TBL] [Abstract][Full Text] [Related]
10. Wilms tumor and the WT1 gene.
Lee SB; Haber DA
Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
[TBL] [Abstract][Full Text] [Related]
11. Expression and roles of Wilms' tumor 1-associating protein in glioblastoma.
Jin DI; Lee SW; Han ME; Kim HJ; Seo SA; Hur GY; Jung S; Kim BS; Oh SO
Cancer Sci; 2012 Dec; 103(12):2102-9. PubMed ID: 22957919
[TBL] [Abstract][Full Text] [Related]
12. Characterization of matrix metalloproteinase-2 and -9, ADAM-10 and N-cadherin expression in human glioblastoma multiforme.
Musumeci G; Magro G; Cardile V; Coco M; Marzagalli R; Castrogiovanni P; Imbesi R; Graziano AC; Barone F; Di Rosa M; Castorina S; Castorina A
Cell Tissue Res; 2015 Oct; 362(1):45-60. PubMed ID: 25948484
[TBL] [Abstract][Full Text] [Related]
13. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
[TBL] [Abstract][Full Text] [Related]
14. Analysis of possible WT1 RNA processing in primary Wilms tumors.
Gunning KB; Cohn SL; Tomlinson GE; Strong LC; Huff V
Oncogene; 1996 Sep; 13(6):1179-85. PubMed ID: 8808692
[TBL] [Abstract][Full Text] [Related]
15. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.
Ge H; Mu L; Jin L; Yang C; Chang YE; Long Y; DeLeon G; Deleyrolle L; Mitchell DA; Kubilis PS; Lu D; Qi J; Gu Y; Lin Z; Huang J
Int J Cancer; 2017 Oct; 141(7):1434-1444. PubMed ID: 28612394
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor protein (-KTS) modulates renin gene transcription.
Steege A; Fähling M; Paliege A; Bondke A; Kirschner KM; Martinka P; Kaps C; Patzak A; Persson PB; Thiele BJ; Scholz H; Mrowka R
Kidney Int; 2008 Aug; 74(4):458-66. PubMed ID: 18496514
[TBL] [Abstract][Full Text] [Related]
17. Gastrin-Releasing Peptide Receptor Knockdown Induces Senescence in Glioblastoma Cells.
Menegotto PR; da Costa Lopez PL; Souza BK; de Farias CB; Filippi-Chiela EC; Vieira IA; Schwartsmann G; Lenz G; Roesler R
Mol Neurobiol; 2017 Mar; 54(2):888-894. PubMed ID: 26780458
[TBL] [Abstract][Full Text] [Related]
18. CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme.
Choy W; Nagasawa DT; Trang A; Thill K; Spasic M; Yang I
Neurosurg Clin N Am; 2012 Jul; 23(3):391-405. PubMed ID: 22748652
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product.
Werner H; Re GG; Drummond IA; Sukhatme VP; Rauscher FJ; Sens DA; Garvin AJ; LeRoith D; Roberts CT
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5828-32. PubMed ID: 8390684
[TBL] [Abstract][Full Text] [Related]
20. The EGFRvIII variant in glioblastoma multiforme.
Gan HK; Kaye AH; Luwor RB
J Clin Neurosci; 2009 Jun; 16(6):748-54. PubMed ID: 19324552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
